Noida, India

Paramvir Bhadwal

This inventor holds 1 USPTO granted patent. Top assignee: Jubilant Organosys Limited. Active years: 2010.


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paramvir Bhadwal: Innovator in Pharmaceutical Processes

Introduction

Paramvir Bhadwal is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of statins. His innovative approach has led to the development of a unique process that enhances the efficiency and sustainability of lactonization.

Latest Patents

Paramvir holds a patent for a process titled "Process for lactonization in the preparation of statins." This invention relates to an improved and industrially friendly method for lactonization to produce compounds from specific formulas. The process involves using an inorganic compound as a suitable lactonizing agent, preferably alkali metal hydrogen sulfate, and crystallizing the obtained lactone product in a solvent. This method also includes treating the compound in the presence of a phase transfer catalyst in a heterogeneous phase, followed by crystallization.

Career Highlights

Paramvir Bhadwal is currently employed at Jubilant Organosys Limited, where he applies his expertise in pharmaceutical processes. His work focuses on developing innovative solutions that improve the production of essential compounds in the industry.

Collaborations

Throughout his career, Paramvir has collaborated with talented professionals such as Govind Singh and Sanjay Jaiswal. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Paramvir Bhadwal's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing industrial processes. His work not only enhances the efficiency of statin production but also reflects the importance of innovation in the pharmaceutical industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…